3d Printing in Pharmaceuticals: Principles, Technologies, Applications and Future Prospects

Three-dimensional (3D) printing has emerged as a disruptive manufacturing technology in pharmaceutical sciences, enabling the fabrication of patient-specific dosage forms with precise control over drug dose, geometry, internal architecture, and release kinetics. By integrating computer-aided design with layer-by-layer material deposition, 3D printing aligns closely with the goals of personalized medicine and on-demand drug manufacturing. This review consolidates the principles, historical evolution, major printing techniques, printable materials, process workflow, regulatory considerations, and wide-ranging applications of pharmaceutical 3D printing. Key technologies—including binder jet printing, fused deposition modeling, semi-solid extrusion, stereolithography, selective laser sintering, and inkjet printing—are discussed with respect to their operational mechanisms, advantages, and limitations in drug formulation. The role of polymers, active pharmaceutical ingredients, excipients, hydrogels, and photopolymers in determining printability and drug release behavior is critically examined. The article further highlights process stages from digital design to post-processing and quality assurance, emphasizing the importance of formulation optimization and process parameters. Applications such as polypills, controlled-release systems, fast-dissolving tablets, implants, microneedles, and point-of-care manufacturing demonstrate the transformative potential of this technology. The approval of the first 3D printed drug, Spritam® (levetiracetam), marked a regulatory milestone, while ongoing developments in bioprinting, organ-on-chip models, and implantable drug delivery devices indicate promising future prospects. Despite challenges related to material limitations, scalability, technical complexity, and evolving regulatory frameworks, continuous advancements are expected to integrate 3D printing into mainstream pharmaceutical manufacturing and precision therapeutics.